The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Graft vs Host Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Graft vs Host Disease


Psychiatry related information on Graft vs Host Disease


High impact information on Graft vs Host Disease


Chemical compound and disease context of Graft vs Host Disease


Biological context of Graft vs Host Disease


Anatomical context of Graft vs Host Disease


Gene context of Graft vs Host Disease


Analytical, diagnostic and therapeutic context of Graft vs Host Disease


  1. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Schwartz, J.C., Zhang, X., Fedorov, A.A., Nathenson, S.G., Almo, S.C. Nature (2001) [Pubmed]
  2. Bone-marrow transplantation for acute leukaemia in first remission. Gale, R.P., Kay, H.E., Rimm, A.A., Bortin, M.M. Lancet (1982) [Pubmed]
  3. Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Aubin, F., Cahn, J.Y., Ferrand, C., Angonin, R., Humbert, P., Tiberghien, P. Lancet (2000) [Pubmed]
  4. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Davies, S.M., Kollman, C., Anasetti, C., Antin, J.H., Gajewski, J., Casper, J.T., Nademanee, A., Noreen, H., King, R., Confer, D., Kernan, N.A. Blood (2000) [Pubmed]
  5. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C., Barrett, J. Blood (1996) [Pubmed]
  6. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Ireland, R.M., Atkinson, K., Concannon, A., Dodds, A., Downs, K., Biggs, J.C. Br. J. Haematol. (1990) [Pubmed]
  7. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. Behar, E., Chao, N.J., Hiraki, D.D., Krishnaswamy, S., Brown, B.W., Zehnder, J.L., Grumet, F.C. N. Engl. J. Med. (1996) [Pubmed]
  8. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. Lucarelli, G., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Andreani, M., Agostinelli, F., Albertini, F., Clift, R.A. N. Engl. J. Med. (1993) [Pubmed]
  9. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. Chao, N.J., Schmidt, G.M., Niland, J.C., Amylon, M.D., Dagis, A.C., Long, G.D., Nademanee, A.P., Negrin, R.S., O'Donnell, M.R., Parker, P.M. N. Engl. J. Med. (1993) [Pubmed]
  10. Thalidomide for the treatment of chronic graft-versus-host disease. Vogelsang, G.B., Farmer, E.R., Hess, A.D., Altamonte, V., Beschorner, W.E., Jabs, D.A., Corio, R.L., Levin, L.S., Colvin, O.M., Wingard, J.R. N. Engl. J. Med. (1992) [Pubmed]
  11. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. Storb, R., Deeg, H.J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Farewell, V. N. Engl. J. Med. (1986) [Pubmed]
  12. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation. Yee, G.C., Self, S.G., McGuire, T.R., Carlin, J., Sanders, J.E., Deeg, H.J. N. Engl. J. Med. (1988) [Pubmed]
  13. A randomized study of the prevention of acute graft-versus-host disease. Ramsay, N.K., Kersey, J.H., Robison, L.L., McGlave, P.B., Woods, W.G., Krivit, W., Kim, T.H., Goldman, A.I., Nesbit, M.E. N. Engl. J. Med. (1982) [Pubmed]
  14. Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. Kernan, N.A., Byers, V., Scannon, P.J., Mischak, R.P., Brochstein, J., Flomenberg, N., Dupont, B., O'Reilly, R.J. JAMA (1988) [Pubmed]
  15. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., Revillard, J.P. J. Clin. Invest. (1998) [Pubmed]
  16. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. Zorn, E., Miklos, D.B., Floyd, B.H., Mattes-Ritz, A., Guo, L., Soiffer, R.J., Antin, J.H., Ritz, J. J. Exp. Med. (2004) [Pubmed]
  17. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Przepiorka, D., Phillips, G.L., Ratanatharathorn, V., Cottler-Fox, M., Sehn, L.H., Antin, J.H., LeBherz, D., Awwad, M., Hope, J., McClain, J.B. Blood (1998) [Pubmed]
  18. Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. van Leeuwen, J.E., van Tol, M.J., Joosten, A.M., Wijnen, J.T., Verweij, P.J., Khan, P.M., Vossen, J.M. Blood (1994) [Pubmed]
  19. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. Chen, Y., Perry, D., Boackle, S.A., Sobel, E.S., Molina, H., Croker, B.P., Morel, L. J. Immunol. (2005) [Pubmed]
  20. Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants. Wu, D.Y., Goldschneider, I. J. Immunol. (1999) [Pubmed]
  21. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. Ash, R.C., Casper, J.T., Chitambar, C.R., Hansen, R., Bunin, N., Truitt, R.L., Lawton, C., Murray, K., Hunter, J., Baxter-Lowe, L.A. N. Engl. J. Med. (1990) [Pubmed]
  22. Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Weinberg, A.D., Bourdette, D.N., Sullivan, T.J., Lemon, M., Wallin, J.J., Maziarz, R., Davey, M., Palida, F., Godfrey, W., Engleman, E., Fulton, R.J., Offner, H., Vandenbark, A.A. Nat. Med. (1996) [Pubmed]
  23. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Ruggeri, L., Mancusi, A., Capanni, M., Martelli, M.F., Velardi, A. Curr. Opin. Immunol. (2005) [Pubmed]
  24. CD34 stem cell dose and development of extensive chronic graft-versus-host disease. Handgretinger, R., Lang, P., Klingebiel, T., Niethammer, D. Blood (2002) [Pubmed]
  25. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Przepiorka, D., Kernan, N.A., Ippoliti, C., Papadopoulos, E.B., Giralt, S., Khouri, I., Lu, J.G., Gajewski, J., Durett, A., Cleary, K., Champlin, R., Andersson, B.S., Light, S. Blood (2000) [Pubmed]
  26. Association between HLA-B antigens and acute graft-versus-host disease. Storb, R., Prentice, R.L., Hansen, J.A., Thomas, E.D. Lancet (1983) [Pubmed]
  27. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Cavet, J., Middleton, P.G., Segall, M., Noreen, H., Davies, S.M., Dickinson, A.M. Blood (1999) [Pubmed]
  28. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Miura, Y., Thoburn, C.J., Bright, E.C., Chen, W., Nakao, S., Hess, A.D. Blood (2002) [Pubmed]
  29. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Flomenberg, N., Baxter-Lowe, L.A., Confer, D., Fernandez-Vina, M., Filipovich, A., Horowitz, M., Hurley, C., Kollman, C., Anasetti, C., Noreen, H., Begovich, A., Hildebrand, W., Petersdorf, E., Schmeckpeper, B., Setterholm, M., Trachtenberg, E., Williams, T., Yunis, E., Weisdorf, D. Blood (2004) [Pubmed]
  30. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Petersdorf, E.W., Kollman, C., Hurley, C.K., Dupont, B., Nademanee, A., Begovich, A.B., Weisdorf, D., McGlave, P. Blood (2001) [Pubmed]
  31. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease. Fischer, A.C., Beschorner, W.E., Hess, A.D. J. Exp. Med. (1989) [Pubmed]
  32. The IL-2/IL-2 receptor system: a target for rational immune intervention. Waldmann, T.A. Immunol. Today (1993) [Pubmed]
  33. Microvasculopathy in the ocular fundus after bone marrow transplantation. Bernauer, W., Gratwohl, A., Keller, A., Daicker, B. Ann. Intern. Med. (1991) [Pubmed]
  34. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Stewart, B.L., Storer, B., Storek, J., Deeg, H.J., Storb, R., Hansen, J.A., Appelbaum, F.R., Carpenter, P.A., Sanders, J.E., Kiem, H.P., Nash, R.A., Petersdorf, E.W., Moravec, C., Morton, A.J., Anasetti, C., Flowers, M.E., Martin, P.J. Blood (2004) [Pubmed]
  35. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Greinix, H.T., Volc-Platzer, B., Rabitsch, W., Gmeinhart, B., Guevara-Pineda, C., Kalhs, P., Krutmann, J., Hönigsmann, H., Ciovica, M., Knobler, R.M. Blood (1998) [Pubmed]
WikiGenes - Universities